Clinical Trial Update: Studies of Elevated Parathyroid Activity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updates on studies of elevated parathyroid activity completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercalcemia
• Hyperparathyroidism
• Men1
• Multiple Endocrine Neoplasia
• Parathyroid Neoplasm

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Hyperparathyroidism, Hypercalcemia | Phase 2 | Status: COMPLETED | Results posted: 2022-06-07